Herbalife

Here's a look at the top tickers trending on StockTwits.com. La Jolla Pharmaceutical: Successful Phase 2 trial results Last night, La Jolla Pharmaceutical (NASDAQ: LJPC) reported that its Phase 2 trial of its GCS-100 chronic kidney disease drug “"met its primary efficacy endpoint of a...

U.S. stocks closed the day slightly lower as investors digested news that China's exports dropped significantly. Philadelphia Fed Chief Charles Plosser said in a speech today that February's harsh winter likely curbed jobs growth in the month. Plosser's remarks echo similar sentiments by other...

Activist Investor Carl Icahn rattled the cage again last week at eBay (NASDAQ: EBAY), one of his top stock picks at the moment, along with Apple (NASDAQ: AAPL), Herbalife (NYSE: HLF) and Netflix (NASDAQ: NFLX). In his latest letter to eBay shareholders, Icahn said he had "not yet begun to fight...

U.S. stocks were mixed despite the S&P 500 hitting new all time highs of 1,867.92. Rumors surrounding Russian military involvement in Ukraine naturally presented investor concerns and fear in the market. The market was boosted by a positive consumer sentiment and a steady existing-home...

Despite being closed on Monday, U.S. markets had a relatively quiet day Tuesday. The Dow lost about 24 points to close at 16,130.40. The S&P was up 0.1 percent, or about two points, to 1,840.76 and the NASDAQ saw a sharp rise to finish 0.7 percent higher at 4,272.78. Wednesday morning, U....

Herbalife (NYSE: HLF) is up more than one percent in after hours trading after the company reported its fourth quarter results. The firm reported a Q4 EPS of $1.28 versus the Street estimate of $1.24. Earnings per share were up 22 percent from the year-ago period. Revenue arrived at $1.27...

The earnings season is winding down, but on the docket this week are Coca-Cola (NYSE: KO), Groupon (NASDAQ: GRPN), Hewlett-Packard (NYSE: HPQ), MGM Resorts (NYSE: MGM), Tesla Motors (NASDAQ: TSLA) and others. Later in the week, the parade of quarterly reports from big retailers kicks off with...

U.S. stocks rose on Friday as investors were able to overlook some disappointing economic data as a result of cold weather. Major indices showed signs of strength today as the Nasdaq continues to inch towards historical all time highs of 5,135.52 recorded on March 10,2000. Today, the index hit...

U.S. stocks took a breather on Wednesday with major indices little changed after one of the largest four-day bull runs in recent history. The House has authorized a one year extension to the government's borrowing authority until March 16, 2015. The Senate gave the final seal of approval this...

As a Latino advocacy group met with a federal regulator Tuesday to discuss their concerns about alleged abuses perpetrated by Herbalife (NYSE: HLF) against Latinos and others, hedge-fund manager Bill Ackman continued his efforts to portray the company as an illegal pyramid scheme. This time...

U.S. stocks continued its losses on an accelerated basis on Monday. Investors are in clear panic mode following a report that U.S manufacturing activity expanded at a slower pace in January. The Dow plunged more than 300 points while the S&P 500 and Nasdaq both fell more than two percent as...

Here's a look at the top tickers trending on StockTwits.com Sina: Record breaking milestone Sina Weibo is the Chinese equivalent of Twitter and set a corporate historical milestone last night. Sina Weibo users “tweeted” 863,408 posts within the first minute of the Chinese New Year, 130,000...

On Wednesday, Pershing Square Capital Management revealed that Shane Dinneen has resigned from the company. Dinneen was the analyst responsible for conducting research on Herbalife (NYSE: HLF) prior to the investment firm initiating its massive short position in the company. In a letter to...

The problems for Herbalife (NYSE: HLF) continue to pile on. On Tuesday the Canadian Competition Bureau, Canada's top consumer regulator, launched a formal inquiry into Herbalife -- which is accused by many, including billionaire hedge fund owner Bill Ackman, of operating a giant pyramid scheme...

Here's a look at the top tickers trending on StockTwits.com Ariad Pharmaceuticals: Buyout rumors persist On Friday, analysts at BMO Capital upgraded Ariad Pharmaceuticals (NASDAQ: ARIA) from Market Perform to Outperform with a price target raised to $14 from a previous $8. The analysts noted...